Zobrazeno 241 - 250
of 14 724
pro vyhledávání: ''
Autor:
S.R. Aravind, Arthur Asirvatham, Jayashri Shembalkar, Ramesh Goyal, Rajesh Gaikwad, Manoj Chawla, Sivakumar Vaidyanathan, Hemant Thacker, Hanmant Barkate, Rahul R. Kodgule, Sagar Katare, Pradnya Kadam, Brij Mohan, Amol Pendse, Hansraj Alva, S. Paramesh, Monika Tandon, R. Balamurugan, Sachin R. Suryawanshi, Mala Dharmalingam
Publikováno v:
Drugs
Background Metformin is the first-line treatment for type 2 diabetes mellitus (T2DM), but many patients either cannot tolerate it or cannot achieve glycemic control with metformin alone, so treatment with other glucose-lowering agents in combination
Autor:
Daniela Giannini, Francesco Oddone, Fabio Scarinci, Monica Varano, Vincenzo Parisi, Mariacristina Parravano, Paola Giorno
Publikováno v:
Advances in Therapy
Introduction This study aimed to evaluate the effect of treatment with eye drops containing citicoline and vitamin B12 on changes in function of the inner retina, morphology of the inner and outer retina, and microvascular condition in patients with
Autor:
Terrilyn Sharpe, Steven Caras
Publikováno v:
Journal of Child and Adolescent Psychopharmacology. 30:69-80
Objectives: We evaluated the pharmacokinetics (PK) of an investigational immediate-release amphetamine (AMP) sulfate formulation (AR19) designed to deter nonoral administration versus reference rac...
Publikováno v:
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-8 (2020)
BMC Pharmacology & Toxicology
BMC Pharmacology & Toxicology
Background Despite the fact that histone deacetylase (HDAC) inhibitors have been tested to treat various cardiovascular diseases, the effects of selective HDAC6 inhibitor ACY1215 on infarct size during cardiac ischemia-reperfusion (IR) injury still r
Publikováno v:
Clinical Therapeutics. 42:448-457
Purpose Ledipasvir/sofosbuvir and sofosbuvir/velpatasvir have been approved worldwide for the treatment of chronic hepatitis C virus (HCV) infection. Although both have been approved in China, there are currently no data on their pharmacokinetic prof
Autor:
Massimo Di Giannantonio, Michele Fornaro, F. Vellante, Giovanni Martinotti, Domenico De Berardis, Gaia Baroni, Laura Orsolini, Alessandro Valchera, Yong Ku Kim
Publikováno v:
International Clinical Psychopharmacology. 35:113-118
Obsessive-compulsive disorder is often associated with schizophrenia and may represent a significant challenge in the treatment as this comorbidity may not respond properly to antipsychotic medication and usually require a pharmacological and psychot
Autor:
Jordi Navarro, Ignacio Santos, Juan González-García, Leire Pérez-Latorre, José Hernández-Quero, Ana Carrero, José Sanz, Enrique Ortega, Juan Berenguer, Javier Hernández Bermejo, José María Bellón, Víctor Hontañón, Luz Maria Medrano, Salvador Resino, Carmen Quereda, María Jesús Téllez, María José Galindo
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 83:292-300
BACKGROUND To assess the effects of eradication of hepatitis C virus (HCV) on cardiovascular risk (CVR) and preclinical atherosclerosis in HIV/HCV-coinfected patients. SETTING Prospective cohort study. METHODS We assessed serum lipids, 10-year Framin
Autor:
Caitlin S Kocherla, Celeste R. Caulder, P. Brandon Bookstaver, Joseph Magagnoli, Zaina P. Qureshi
Publikováno v:
Annals of Pharmacotherapy. 54:852-857
Background: Sulfamethoxazole-trimethoprim (SXT) therapy is commonly used in HIV-infected patients and is associated with hyperkalemia and elevated serum creatinine (SCr). Objective: The purpose of this study was to examine the frequency of hyperkalem
Autor:
P. Kellie Turner, Gemma L. Dickinson, Stephen D. Hall, Palaniappan Kulanthaivel, Bridget L. Morse, Maria M. Posada
Publikováno v:
Journal of Clinical Pharmacology
Abemaciclib, a selective inhibitor of cyclin‐dependent kinases 4 and 6, is metabolized mainly by cytochrome P450 (CYP)3A4. Clinical studies were performed to assess the impact of strong inhibitor (clarithromycin) and inducer (rifampin) on the expos
Publikováno v:
Expert Opinion on Pharmacotherapy. 21:603-612
Introduction: Androgenetic alopecia is a common hair loss disorder affecting up to 80% of males by the age of 80. It is characterized by androgen related progressive thinning of hair in a defined pattern. It results in diminished self-esteem, reduced